HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Friday, 11 February 2011

New NICE appraisals starting soon

The following NICE topics have been allocated to the ScHARR Technology Appraisal Group (ScHARR-TAG) and work will start soon:

Rivaroxaban (Xarelto) for the prevention of venous thromboembolism in people
hospitalised for acute medical conditions

Rivaroxaban (Xarelto) for deep vein thrombosis (symptomatic) and the prevention of
recurrent deep vein thrombosis and pulmonary embolism
Both are single technology appraisals.  For further details, contact Eva Kaltenthaler or Matt Stevenson.